.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Longitudinal Assessment of Bariatric Surgery (LABS) study followed patients for seven years after bariatric procedures, providing valuable evidence on the durability of outcomes beyond the early postoperative period. Long-term data are especially important in bariatric surgery because weight regain, recurrence of metabolic disease and late complications can influence the real-world value of an operation. At seven years, Roux-en-Y gastric bypass was associated with substantial sustained weight loss, with a greater average reduction than laparoscopic adjustable gastric banding in the study population. Diabetes remission also remained considerably more common after gastric bypass. For surgeons and multidisciplinary teams, the findings reinforce two principles. First, bariatric surgery can produce durable changes in weight and metabolic disease. Second, outcomes need to be interpreted over years rather than months, because the clinical trajectory continues long after the initial operation. The study also highlights why long-term follow-up is not optional. Nutritional monitoring, management of medications, surveillance for recurrence of obesity-related disease and assessment of quality of life remain essential parts of bariatric care. LABS therefore provides a useful framework for counselling patients: the goal is durable improvement in health, not simply an early postoperative reduction in weight.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Longitudinal Assessment of Bariatric Surgery (LABS) study followed patients for seven years after bariatric procedures, providing valuable evidence on the durability of outcomes beyond the early postoperative period. Long-term data are especially important in bariatric surgery because weight regain, recurrence of metabolic disease and late complications can influence the real-world value of an operation. At seven years, Roux-en-Y gastric bypass was associated with substantial sustained weight loss, with a greater average reduction than laparoscopic adjustable gastric banding in the study population. Diabetes remission also remained considerably more common after gastric bypass. For surgeons and multidisciplinary teams, the findings reinforce two principles. First, bariatric surgery can produce durable changes in weight and metabolic disease. Second, outcomes need to be interpreted over years rather than months, because the clinical trajectory continues long after the initial operation. The study also highlights why long-term follow-up is not optional. Nutritional monitoring, management of medications, surveillance for recurrence of obesity-related disease and assessment of quality of life remain essential parts of bariatric care. LABS therefore provides a useful framework for counselling patients: the goal is durable improvement in health, not simply an early postoperative reduction in weight.
Yesterday
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
